Drug Trial Radar · NCT07463183
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Mar 24, 2026
Primary completion
Oct 28, 2027
Study completion Dec 21, 2028
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Mar 11, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Score at Week 12.
Conditions
- Colitis Ulcerative
- Ulcerative Colitis
Interventions
MK-8690Drug
Solution for subcutaneous injection
PlaceboOther
Solution for subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Clinical Remission Per Modified Mayo Score (MMS) at Week 12Time frame: Week 12
Locations
43 sites in 12 countries. Site status is shown where the registry gives one.
Clinnova Research ( Site 1042)
Anaheim, California · Recruiting
Southern California Research Center ( Site 1044)
Coronado, California · Recruiting
Peak Gastroenterology Associates ( Site 1052)
Colorado Springs, Colorado · Recruiting
South Denver Gastroenterology, PC ( Site 1068)
Englewood, Colorado · Recruiting
Nature Coast Clinical Research ( Site 1045)
Inverness, Florida · Recruiting
Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072)
Miami, Florida · Recruiting
AdventHealth Orlando ( Site 1074)
Orlando, Florida · Recruiting
Gastroenterology Associates of Central Georgia ( Site 1060)
Macon, Georgia · Recruiting
University of Kansas Medical Center ( Site 1077)
Kansas City, Kansas · Recruiting
Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073)
New Orleans, Louisiana · Recruiting
BVL Research - Kansas ( Site 1054)
Liberty, Missouri · Recruiting
Prairie Institute of Liver and Luminal Advanced Research ( Site 1008)
Lethbridge, Alberta, Canada · Recruiting
Toronto Western Hospital ( Site 1006)
Toronto, Ontario, Canada · Recruiting
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 1001)
Montreal, Quebec, Canada · Recruiting
Hospital Clinico Regional Dr. Guillermo Grant Benavente ( Site 1129)
Concepción, Biobio, Chile · Recruiting
Clinica Alemana de Santiago ( Site 1124)
Santiago, Region M. de Santiago, Chile · Recruiting
Clínica MEDS La Dehesa ( Site 1123)
Santiago, Region M. de Santiago, Chile · Recruiting
Servicios de Salud IPS Suramericana S.A.S. - IPS Sura Industriales Medellín ( Site 1163)
Medellín, Antioquia, Colombia · Recruiting
Clinica de la Costa S.A.S. ( Site 1161)
Barranquilla, Atlántico, Colombia · Recruiting
Fundacion Santa Fe de Bogota ( Site 1165)
Bogota, Cundinamarca, Colombia · Recruiting
Fundación Valle del Lili ( Site 1162)
Cali, Valle del Cauca Department, Colombia · Recruiting
Centre Hospitalier Dr Schaffner ( Site 1288)
Lens, Pas-de-Calais, France · Recruiting
Clinique Jules Verne ( Site 1284)
Nantes, Pays de la Loire Region, France · Recruiting
Universitätsklinikum Brandenburg an der Havel ( Site 1323)
Brandenburg, Germany · Recruiting
Universitaetsklinikum Ulm. ( Site 1324)
Ulm, Baden-Wurttemberg, Germany · Recruiting
Evangelismos General Hospital of Athens ( Site 1362)
Athens, Attica, Greece · Recruiting
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA" ( Site 1361)
Athens, Attica, Greece · Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1404)
Bologna, Emilia-Romagna, Italy · Recruiting
Istituto Clinico Humanitas-IBD center ( Site 1401)
Rozzano, Milano, Italy · Recruiting
Radboudumc ( Site 1650)
Nijmegen, Gelderland, Netherlands · Recruiting
Amsterdam UMC, locatie VUmc ( Site 1651)
Amsterdam, North Holland, Netherlands · Recruiting
Promed P. Lach R. Glowacki s.j. Centrum Medyczne Promed ( Site 1447)
Krakow, Lesser Poland Voivodeship, Poland · Recruiting
Melita Medical Sp Zoo ( Site 1442)
Wroclaw, Lower Silesian Voivodeship, Poland · Recruiting
EB Group Sp. Z o.o. Centrum Zdrowia MDM ( Site 1449)
Warsaw, Masovian Voivodeship, Poland · Recruiting
Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś ( Site 1448)
Warsaw, Masovian Voivodeship, Poland · Recruiting
Twoja Przychodnia - Szczeciskie Centrum Medyczne ( Site 1450)
Szczecin, West Pomeranian Voivodeship, Poland · Recruiting
Kangbuk Samsung Hospital ( Site 1601)
Seoul, South Korea · Recruiting
Wonju Severance Christian Hospital ( Site 1602)
Wŏnju, Kang-won-do, South Korea · Recruiting
Korea University Ansan Hospital ( Site 1603)
Ansan-si, Kyonggi-do, South Korea · Recruiting
Addenbrooke's Hospital ( Site 1525)
Cambridge, Cambridgeshire, United Kingdom · Recruiting
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.